HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria.

Abstract
Progerias are rare genetic diseases characterized by premature aging. Several progeroid disorders are caused by mutations that lead to the accumulation of a lipid-modified (farnesylated) form of prelamin A, a protein that contributes to the structural scaffolding for the cell nucleus. In progeria, the accumulation of farnesyl-prelamin A disrupts this scaffolding, leading to misshapen nuclei. Previous studies have shown that farnesyltransferase inhibitors (FTIs) reverse this cellular abnormality. We tested the efficacy of an FTI (ABT-100) in Zmpste24-deficient mice, a mouse model of progeria. The FTI-treated mice exhibited improved body weight, grip strength, bone integrity, and percent survival at 20 weeks of age. These results suggest that FTIs may have beneficial effects in humans with progeria.
AuthorsLoren G Fong, David Frost, Margarita Meta, Xin Qiao, Shao H Yang, Catherine Coffinier, Stephen G Young
JournalScience (New York, N.Y.) (Science) Vol. 311 Issue 5767 Pg. 1621-3 (Mar 17 2006) ISSN: 1095-9203 [Electronic] United States
PMID16484451 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ABT-100
  • Enzyme Inhibitors
  • Imidazoles
  • Lamin Type A
  • Membrane Proteins
  • Nuclear Proteins
  • Protein Precursors
  • prelamin A
  • Farnesyltranstransferase
  • Metalloendopeptidases
  • Zmpste24 protein, mouse
Topics
  • Animals
  • Body Weight (drug effects)
  • Disease Models, Animal
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • Farnesyltranstransferase (antagonists & inhibitors)
  • Female
  • Hand Strength
  • Imidazoles (pharmacology, therapeutic use)
  • Lamin Type A
  • Male
  • Membrane Proteins (deficiency, genetics)
  • Metalloendopeptidases (deficiency, genetics)
  • Mice
  • Nuclear Proteins (metabolism)
  • Progeria (drug therapy, physiopathology)
  • Protein Precursors (metabolism)
  • Protein Prenylation (drug effects)
  • Rib Fractures (prevention & control)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: